Search

everythinglearnresearchcommunity

for

Search:↓

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Topical eflornithine helps maintain hair reduction after IPL therapy in women with facial hirsutism.

Cooling with antioxidants helps protect hair during chemotherapy.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Cetuximab can cause skin cysts after acne-like eruptions.

Scalp cooling and minoxidil can help manage hair loss after chemotherapy.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Biobran MGN-3 reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Gefitinib therapy can cause unusual hair growth on the nose.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Juniperus communis extract enhances the effectiveness of oral cancer treatment when combined with chemotherapy.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

MK-5108 is safe and shows potential against tumors, especially alone.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Erlotinib can cause persistent excessive hair growth.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

Eclipta alba extract may help fight cancer and has antioxidant benefits without being toxic.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.